AlanWerzbergerMD

PubMed

• 1 citations
  Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
  Rachel Gross, Tanayott Thaweethai, Erika B Rosenzweig, James Chan, Lori B Chibnik, Mine S Cicek, Amy J Elliott, Valerie J Flaherman, Andrea S Foulkes, Margot Gage Witv...> ;Medrxiv. 2023 May 12
• Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control.
  Alan Werzberger, Juan Manuel Carreño, Sinai Serocore Team, Adam Polinger, Florian Krammer, Philip Zachariah> ;American Journal of Infection Control. 2021 Aug 20
• 36 citations
  A Recessive Gene for Primary Vesicoureteral Reflux Maps to Chromosome 12p11-q13
  Patricia L. Weng, Simone Sanna-Cherchi, Terry W. Hensle, Ellen Shapiro, Alan Werzberger, Gianluca Caridi, Claudia Izzi, Anita Konka, Adam C. Reese, Rong Cheng, Samuel ...> ;Journal of the American Society of Nephrology. 2009 Jul 1
• 10 citations
  Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
  Fernando A. Guerra, Jacqueline Gress, Alan Werzberger, Keith S. Reisinger, Emmanuel B. Walter, Hassan Lakkis, Anthony D. Grosso, Carolee Welebob, Barbara J. Kuter, Sta...> ;The Pediatric Infectious Disease Journal. 2006 Oct 1
• 34 citations
  The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence...
  Jay M. Lieberman, Wendy R. Williams, Jacqueline M. Miller, Steven Black, Henry R. Shinefield, Frederick W. Henderson, Colin D. Marchant, Alan Werzberger, Scott A. Halp...> ;The Pediatric Infectious Disease Journal. 2006 Jul 1
• 27 citations
  Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA.
  Alan Werzberger, Barbara Mensch, David R. Nalin, Barbara J. Kuter> ;Vaccine. 2002 Mar 15
• 15 citations
  Inactivated hepatitis A vaccine in childhood: implications for disease control
  David R. Nalin, Leora Brown, Barbara J. Kuter, C M Patterson, B. McGuire, Alan Werzberger, M. Santosham, Stan L. Block, Keith S. Reisinger, Barbara Watson, Stuart E. S...> ;Vaccine. 1993 Jan 1
• 53 citations
  Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations : an overview
  David R. Nalin, Barbara J. Kuter, Leora Brown, Carol Patterson, Gary B. Calandra, Alan Werzberger, Daniel Shouval, Edward F. Ellerbeck, Stanley L. Block, Robert Bishop...> ;Journal of Hepatology. 1993 Jan 1
• 13 citations
  Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial
  Alan Werzberger, Barbara J. Kuter, Daniel Shouval, Barbara Mensch, Leora Brown, Brian L. Wiens, John A. Lewis, William J. Miller, Robert D. Sitrin, Philip J. Provost, ...> ;Journal of Hepatology. 1993 Jan 1
• 376 citations
  A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
  Alan Werzberger, B Mensch, Barbara J. Kuter, Leora Brown, J Lewis, R Sitrin, William C. Miller, Daniel Shouval, B Wiens, Gary B. Calandra> ;The New England Journal of Medicine. 1992 Aug 13
• Six years' follow-up after hepatitis A vaccination.
  Werzberger, A., Kuter, B., Nalin, D.> ;N Engl J Med. 1998 Apr 16
• The role of young children in a community-wide outbreak of hepatitis A.
  Smith, P. F., Grabau, J. C., Werzberger, A., Gunn, R. A., Rolka, H. R., Kondracki, S. F., Gallo, R. J., Morse, D. L.> ;Epidemiol Infect. 1997 Jun
• Join now to see all